Fort Washington Investment Advisors Inc Biomarin Pharmaceutical Inc Transaction History
Fort Washington Investment Advisors Inc
- $15.8 Billion
- Q1 2025
A detailed history of Fort Washington Investment Advisors Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 715,049 shares of BMRN stock, worth $41.9 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
715,049
Previous 715,500
0.06%
Holding current value
$41.9 Million
Previous $47 Million
7.48%
% of portfolio
0.32%
Previous 0.29%
Shares
21 transactions
Others Institutions Holding BMRN
# of Institutions
631Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.33 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.14 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.07 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$865 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$762 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...